Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Aikawa

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Nihon Geka Gakkai Zasshi|July 28, 2005
[Hospital rankings by number of surgeries ]Naoki Aikawa
Pulmonary Pharmacology & Therapeutics|February 23, 2013
The propensity score analysis on the efficacy of Sivelestat - author's replyNaoki Aikawa
Nihon Geka Gakkai Zasshi|July 28, 2006
[Advances in surgical sciences and improved outcome in the treatment of severe burns]Naoki Aikawa
Nihon Geka Gakkai Zasshi|January 22, 2004
[Phathophysiological response to surgical insults: new findings]Naoki Aikawa
Burns : Journal of the International Society for Burn Injuries|December 5, 2002
A message from the presidentNaoki Aikawa
Nihon Geka Gakkai Zasshi|May 2, 2003
[Compulsory postgraduate clinical training and surgical education]Naoki Aikawa
The Japanese Journal of Antibiotics|July 27, 2011
[Revised Surviving Sepsis Campaign Guidelines and therapy for severe sepsis]Naoki Aikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 30, 2003
[Sepsis]Yoshio Kobayashi, Naoki Aikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2004
[Pathophysiology of hypercytokinemia]Seitaro Fujishima, Naoki Aikawa
Therapeutics and Clinical Risk Management|August 15, 2014
Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndromeNaoki Aikawa, Yasushi Kawasaki
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Nihon Geka Gakkai Zasshi|July 28, 2005
[Hospital rankings by number of surgeries ]Naoki Aikawa
Pulmonary Pharmacology & Therapeutics|February 23, 2013
The propensity score analysis on the efficacy of Sivelestat - author's replyNaoki Aikawa
Nihon Geka Gakkai Zasshi|July 28, 2006
[Advances in surgical sciences and improved outcome in the treatment of severe burns]Naoki Aikawa
Nihon Geka Gakkai Zasshi|January 22, 2004
[Phathophysiological response to surgical insults: new findings]Naoki Aikawa
Burns : Journal of the International Society for Burn Injuries|December 5, 2002
A message from the presidentNaoki Aikawa
Nihon Geka Gakkai Zasshi|May 2, 2003
[Compulsory postgraduate clinical training and surgical education]Naoki Aikawa
The Japanese Journal of Antibiotics|July 27, 2011
[Revised Surviving Sepsis Campaign Guidelines and therapy for severe sepsis]Naoki Aikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 30, 2003
[Sepsis]Yoshio Kobayashi, Naoki Aikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2004
[Pathophysiology of hypercytokinemia]Seitaro Fujishima, Naoki Aikawa
Therapeutics and Clinical Risk Management|August 15, 2014
Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndromeNaoki Aikawa, Yasushi Kawasaki
Pageof 11